PCI High Potent Manufacturing
LB Bohle – 10.06.2025
Temax_Krautz

Current Edition

Current Edition

Subsection - CDMO

Examining how innovative technologies, integrated manufacturing approaches and AI are shaping manufacturing.

Continue reading

Subsection - Injectables

Exploring advances in injectable drug delivery and sterile manufacturing, designed to improve patient-centric delivery.

Continue reading

Subsection - Neurodegenerative Diseases

Exploring emerging approaches to neurodegenerative disease research and treatment.

Continue reading

Subsection - Nasal & Pulmonary

Highlighting how advances in nasal and pulmonary drug delivery, formulation, devices and analytics are enabling more complex therapies.

Continue reading

Advertisement

CPHI 2027
DDL 2026

Advertisement

Nipro August 26

Advertisement

Merxin March 2026

Advertisement

Aurisco 300×250

Advertisement

Lifecore Biomedical

ABPI chief exec says no-deal Brexit is ‘not in the interest of patients’

Following prime minister Boris Johnson’s announcement last week that he was preparing for a no-deal with the EU, the Association for the British Pharmaceutical Industry (ABPI) has warned against such an outcome.

Responding to the prime minister’s announcement, ABPI chief executive Richard Torbett said: “No deal is not in the interest of patients, the pharmaceutical industry, or the economies of the UK and the EU.”

“As long as a window of opportunity remains, negotiators must keep talking and agree a comprehensive deal,” he added.

In particular, Torbett highlighted potential medicines supply issues and disruptions for key drugs between the EU and the UK. Torbett told the Independent that pharma companies have stockpiled of certain drugs in case of shortages in the new year.

“[Negotiators] must ensure medicines supplies are uninterrupted and that a way forward for patients in Northern Ireland is urgently found,” said Torbett.

“Our members are preparing for the end of the transition period at the same time as coronavirus cases rise across Europe. This should be enough to focus minds,” he added.

In the face of the ongoing coronavirus pandemic, the need for harmony between the EU and the UK has never been so urgent, said Torbett.

Advertisement

MedPharm 16/07

Advertisement

Biopharma group march 2026

Advertisement

Silgan March 2026

Advertisement

Terumo 06/26

Advertisement

Scott Pharma – 25.03.2025

Advertisement

Bespak

Advertisement

Solstice

Advertisement

Bachem skyscraper
Tjoapack
Aptar – 08/01/2026